Life sciences software company Synthace has raised $35 million (€30.6M) in Series C funding to expand the reach of its research and development (R&D) cloud platform, where scientists can record and share their research and insights.
The R&D-focused, no-code software platform enables scientists to share, view and access progress with cures and therapeutics in one place, making it simpler...
